GMO Intl Intrinsic Value M
40 Rowes Wharf, Boston, Massachusetts, USA
Phone: 800-225-5291
| Category: | Foreign Large Value | | Fund Family: | GMO | | Net Assets: | 11.89M | | Year-to-Date Return: | 1.64% | | Yield: | 4.72% | | Morningstar Rating: |  | | Fund Inception Date: | 02-Oct-03 |
|
Thomas Hancock
Lead Manager since
31-Dec-98 | | | Hancock is co-head of the GMO quantitative equity team and lead manager for international quantitative portfolios. Prior to joining GMO in 1995, he was a research scientist at Siemens and a software engineer at IBM. |
| Min Initial Investment: | $0 | | Min Initial Investment, IRA: | NaN | | Min Initial Investment, AIP: | NaN | | Min Subsequent Investment: | NaN | | Min Subsequent Investment, IRA: | N/A | | Min Subsequent Investment, AIP: | N/A |
|
| |
| The investment seeks high total return. The fund primarily invests in common stocks of non-U.S. issuers, including dividend-paying common stocks. It maintains investments in no fewer than three foreign countries. The relative emphasis on capital appreciation or income depends on the views of management. To determine geographic allocation, management evaluates the growth potential of different markets, currency and taxation considerations, and other pertinent social, financial, political, and national factors. The fund may also enter into various derivative transactions for hedging and risk-management purposes. |
| Last Dividend
(18-Dec-08):
| 0.48 | | Last Cap Gain
(14-Jul-08):
| 1.62 | | Annual Holdings Turnover
| 53.00% | | Average for Category:
| 46.99% |
|
| Expense | GMVMX | Category
Avg | | Total Expense Ratio: | 0.95%
| 1.53% | | Max 12b1 Fee: | 0.25%
| N/A | | Max Front End Sales Load: | %
| 5.48% | | Max Deferred Sales Load: | %
| 2.56% | | 3 Yr Expense Projection*: |
$313 | $683 | | 5 Yr Expense Projection*: |
$548 | $942 | | 10 Yr Expense Projection*: |
$1,220 | $1,888 |
|
|
0.40 (2.14%)
